Intellia Therapeutics Blog | Talkmarkets

Latest Posts

Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum

Article By: Rod Raynovich

Saturday, November 30, 2019 11:38 PM EST

IBB is up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %. The big winners for the month include NTLA up 47.24%.

In this article: IBB, QQQ, XBI, SRPT, NTLA, CRSP

Read

CRISPR Stocks Rise After Chinese Researcher Claims First Gene-Edited Babies

Article By: The Fly

Monday, November 26, 2018 1:47 PM EST

Shares of Crispr Therapeutics, Editas Medicine and Intellia Therapeutics are on the rise after a Chinese researcher claimed that he helped make the world's first genetically edited babies.

In this article: CRSP, EDIT, NTLA Also: SGMO

Read

Winners Of Q1 Earnings: 5 Best ETF Charts

Article By: Sweta Killa

Sunday, May 27, 2018 4:01 PM EST

several equity ETFs have impressed with their performances and generated handsome returns over the trailing one month even after being hit by the trade worries and geopolitical tensions. Here are five ETFs that buoyed up on robust earnings results.

In this article: PTH, SPY, PSCE, GAMR, ARKK, ILMN, SSYS, TSLA, EDIT, NTLA, MKSI, FTXL

Read

Is Ardelyx Inc A Good Stock To Buy Right Now?

Article By: Insider Monkey

Saturday, December 10, 2016 5:20 PM EST

ARDX was in 13 hedge funds' portfolios at the end of September up from nine the previous quarter. The level and the change in hedge fund popularity aren't the only variables you need to analyze to decipher hedge funds' perspectives.

In this article: NPK, TCBK, ARDX, NTLA

Read